Salivary IgA and vimentin differentiate in vitro SARS-CoV-2 infection: A study of 290 convalescent COVID-19 patients
Open Access
- 24 November 2023
- journal article
- research article
- Published by Elsevier in Mucosal Immunology
- Vol. 17 (1) , 124-136
Abstract
No abstract availableKeywords
Funding Information
- Wellcome Trust (212516/Z/18/Z)
- NIHR Great Ormond Street Hospital Biomedical Research Centre
- UKRI
- Biotechnology and Biological Sciences Research Council
- National Institute for Health and Care Research (17DD08)
- Great Ormond Street Hospital Children's Charity (COVID_CSmith_017)
- Animal Free Research UK (AFR19-20274)
- Great Ormond Street Hospital for Children
This publication has 62 references indexed in Scilit:
- Surface vimentin is critical for the cell entry of SARS-CoVJournal of Biomedical Science, 2016
- Antimicrobial Defense Systems in Saliva2014
- High Levels of S100A8/A9 Proteins Aggravate Ventilator-Induced Lung Injury via TLR4 SignalingPLOS ONE, 2013
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Salivary Defense Proteins: Their Network and Role in Innate and Acquired Oral ImmunityInternational Journal of Molecular Sciences, 2012
- Multiple components contribute to ability of saliva to inhibit influenza virusesOral Microbiology and Immunology, 2008
- The use of salivary biomarkers in occupational and environmental medicineOccupational and Environmental Medicine, 2007
- Impact of saliva collection methods on sIgA and cortisol assays and acceptability to participantsJournal of Immunological Methods, 2005
- Secretory IgA antibodies provide cross‐protection against infection with different strains of influenza B virusJournal of Medical Virology, 2004
- Immunosenescence and mucosal immunity: significant effects of old age on secretory IgA concentrations and intraepithelial lymphocyte counts.Gut, 1992